{
  "articles": [
    {
      "path": "contact.html",
      "author": [],
      "contents": "\r\nConnect with me on\r\nTwitter,\r\nGitHub, and\r\nLinkedin.\r\nI am happy to answer gtsummary questions, but please do\r\nnot email me with questions. It is best for the community if\r\nquestions are asked and answered on a public forum.\r\nQuestions? Post to stackoverflow.com, use the\r\ngtsummary tag, and I will be notified of your post.\r\nBug Reports? File a GitHub\r\nIssue\r\n\r\n\r\n\r\n\r\nMemorial Sloan\r\nKettering Cancer Center\r\n1275 York Ave. New York, NY 10065sjobergd@mskcc.org\r\n\r\n\r\n\r\n\r\n\r\nColumbia University\r\nMailman School of Public Health Department of Biostatistics\r\n722 West 168th St., 6th floor New York, NY 10032dds2149@cumc.columbia.edu\r\n\r\n\r\n\r\n\r\n",
      "last_modified": "2022-04-18T21:37:37-04:00"
    },
    {
      "path": "index.html",
      "title": "Daniel D. Sjoberg",
      "author": [],
      "contents": "\r\n\r\nd-article {\r\n  padding-top: 5px;\r\n  border-top: 0px;\r\n}\r\n\r\nd-title h1 {\r\n  text-align: center;\r\n  font-family: Roboto Mono;\r\n  letter-spacing: 3px;\r\n}\r\n\r\nd-title p {\r\n  text-align: center;\r\n}\r\n\r\n.about p {\r\n  text-align: justify;\r\n}\r\n\r\n.hero-left img {\r\n  width: 100%;\r\n  border-radius: 15%;\r\n  border: 3px solid grey;\r\n  display: block;\r\n  margin-left: auto;\r\n  margin-right: auto;\r\n  margin-bottom: 1em;\r\n}\r\n\r\n.hero-right p {\r\n  margin: 10px 0px 10px 0px;\r\n  font-size: 1.2em;\r\n  font-family: Roboto Slab;\r\n}\r\n\r\n.hero-right li {\r\n  margin-bottom: 5px;\r\n  padding-left: 10px;\r\n}\r\n\r\n@media (min-width: 1200px) {\r\n  .hero-left {\r\n    width:32%;\r\n    float:left;\r\n  }\r\n  .hero-right {\r\n    width:63%;\r\n    float:right;\r\n  }\r\n}\r\n\r\n@media (max-width: 1199px) {\r\n  .hero-left img {\r\n    width: 50%;\r\n  }\r\n}\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\nEducation\r\n\r\n\r\nDrPH Candidate Columbia University, Biostatistics\r\n\r\n\r\nMA Boston University, Biostatistics\r\n\r\n\r\nBS University of Utah, Mathematics\r\n\r\n\r\n\r\nWork\r\n\r\n\r\nMemorial Sloan Kettering Cancer Center\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\nabout\r\n\r\n\r\nI am a Senior Biostatistician at\r\nMemorial Sloan\r\nKettering Cancer Center in New York City. I am also a DrPH candidate\r\nin Biostatistics\r\nat\r\nColumbia University. My research interests include adaptive methods\r\nin clinical trials, precision medicine, predictive modeling, and\r\nprostate cancer screening methods. In my time away from work and school,\r\nI enjoy baking, going to the beach, running, and programing in R.\r\n\r\n\r\n\r\n\r\n\r\n\r\n",
      "last_modified": "2022-04-18T21:42:59-04:00"
    },
    {
      "path": "publications.html",
      "author": [],
      "contents": "\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\nFor the most up to date list of publications, check out my\r\nGoogle\r\nScholar page.\r\nPeer-reviewed Publications\r\n\r\nDD Sjoberg, K Whiting, M Curry, JA Lavery, J\r\nLarmarange (2021). “Reproducible Summary Tables with the gtsummary\r\nPackage..” R Journal, 13 (1)DD\r\nSjoberg, AJ Vickers, M Assel, A Dahlin, BY Poon, D Ulmert, H\r\nLilja (2018). “Twenty-year risk of prostate cancer death by midlife\r\nprostate-specific antigen and a panel of four kallikrein markers in a\r\nlarge population-based cohort of healthy men.” European urology, 73\r\n(6), 941-948DD Sjoberg (2014). “Toward a\r\nsmarter prostate cancer screening program..” European Urology, 68\r\n(4), 598-599MA Preston, JL Batista, KM Wilson, SV Carlsson,\r\nT Gerke, DD Sjoberg, and others (2016). “Baseline\r\nprostate-specific antigen levels in midlife predict lethal prostate\r\ncancer.” Journal of Clinical Oncology, 34 (23), 2705GT\r\nChesnut, AL Tin, KA Fleshner, NE Benfante, AJ Vickers, JA Eastham,\r\nDD Sjoberg, and others (2022). “Correction: Estimating\r\npatient health in prostate cancer treatment counseling.” Prostate\r\ncancer and prostatic diseases, KM Kan, AL Tin, GL Stearns,\r\nJA Eastham, DD Sjoberg, JS Sandhu (2022). “De Novo\r\nUrinary Storage Symptoms Are Common after Radical Prostatectomy:\r\nIncidence, Natural History and Predictors.” The Journal of urology,\r\n207 (3), 601-608S Dason, EA Vertosick, K Udo, DD\r\nSjoberg, AJ Vickers, H Al-Ahmadie, and others (2022). “Clinical\r\nutility of subclassifying positive surgical margins at radical\r\nprostatectomy.” BJU international, 129 (2), 194-200GA\r\nJibara, M Perera, EA Vertosick, DD Sjoberg, A Vickers,\r\nPT Scardino, and others (2022). “Association of Family History of Cancer\r\nwith Clinical and Pathological Outcomes for Prostate Cancer Patients on\r\nActive Surveillance.” The Journal of Urology, 10.1097/JU.\r\n0000000000002668KA Touijer, DD Sjoberg, N\r\nBenfante, VP Laudone, B Ehdaie, JA Eastham, and others (2021). “Limited\r\nversus extended pelvic lymph node dissection for prostate cancer: a\r\nrandomized clinical trial.” European Urology Oncology, 4 (4),\r\n532-539M Nyberg, DD Sjoberg, SV Carlsson,\r\nU Wilderäng, S Carlsson, J Stranne, and others (2021). “Surgeon\r\nheterogeneity significantly affects functional and oncological outcomes\r\nafter radical prostatectomy in the Swedish LAPPRO trial.” Bju\r\nInternational, 127 (3), 361GT Chesnut, AL Tin, DD\r\nSjoberg, B Jang, N Benfante, S Sarraf, H Herr, and others\r\n(2021). “Electronic rapid fitness assessment identifies factors\r\nassociated with adverse early postoperative outcomes following radical\r\ncystectomy.” The Journal of urology, 205 (2), 400-406CR\r\nTracy, KJ Flynn, DD Sjoberg, PT Gellhaus, CM Metz, B\r\nEhdaie (2021). “Optimizing MRI-targeted prostate biopsy: the diagnostic\r\nbenefit of additional targeted biopsy cores.” Urologic Oncology:\r\nSeminars and Original Investigations, 39 (3), 193. e1-193.\r\ne6T Stonier, AL Tin, DD Sjoberg, G Jibara,\r\nAJ Vickers, S Fine, J Eastham (2021). “Selecting patients with favorable\r\nrisk, grade group 2 prostate cancer for active surveillance—does\r\nmagnetic resonance imaging have a role?.” The Journal of Urology,\r\n205 (4), 1063-1068B Ehdaie, G Jibara, DD\r\nSjoberg, V Laudone, J Eastham, K Touijer, and others (2021).\r\n“The duration of antibiotics prophylaxis at the time of catheter removal\r\nafter radical prostatectomy: clinically integrated, cluster, randomized\r\ntrial.” The Journal of Urology, 206 (3), 662-668GL\r\nStearns, AL Tin, NE Benfante, DD Sjoberg, JS Sandhu\r\n(2021). “Outcomes of Ureteroneocystostomy in Patients With Cancer.”\r\nUrology, 158, 131-134GT Chesnut, AL Tin, KA Fleshner,\r\nNE Benfante, AJ Vickers, JA Eastham, DD Sjoberg, and\r\nothers (2021). “Estimating patient health in prostate cancer treatment\r\ncounseling.” Prostate cancer and prostatic diseases,\r\n1-5RG Alvim, AL Tin, L Nogueira, NC Wong, RC Fonseca,\r\nDD Sjoberg, and others (2021). “Functional and\r\nOncological Outcomes of Renal Surgery for Hilar Tumors: Informing the\r\nDecisions in Risk-Adapted Management.” Urology, 157,\r\n174-180H Herr, EA Vertosick, G Dalbagni, EK Cha, R Smith, N\r\nBenfante, DD Sjoberg, and others (2021). “Prospective\r\nPhase II Study to Evaluate Response to Two Induction Courses (12\r\nintravesical instillations) of BCG Therapy for High-risk\r\nNon–muscle-invasive Bladder Cancer.” Urology, 157,\r\n197-200G Jibara, DD Sjoberg, GL Stearns, Y\r\nStabholz, A Fathollahi, LS Leddy, and others (2021). “Photoselective\r\nVaporization of the Prostate in the Management of Lower Urinary Tract\r\nSymptoms in Prostate Cancer Patients on Active Surveillance.”\r\nUrology, 156, 225-230CA BRAVI, G ROSIELLO, G FALLARA, E\r\nVERTOSICK, A TIN, DD Sjoberg, and others (2021).\r\n“Minerva Urology and Nephrology 2021 August; 73 (4): 481-8.”\r\nMinerva, 73GT Chesnut, AL Tin, A Sivaraman, T Takeda, T\r\nLee, J Fainberg, DD Sjoberg, and others (2021).\r\n“Defining the index lesion for potential salvage partial or hemi-gland\r\nablation after radiation therapy for localized prostate cancer.”\r\nUrologic Oncology: Seminars and Original Investigations, 39 (8),\r\n495. e17-495 …PE Lonergan, EA Vertosick, M Assel,\r\nDD Sjoberg, A Haese, M Graefen, and others (2021).\r\n“Prospective validation of microseminoprotein-ß added to the 4Kscore in\r\npredicting high-grade prostate cancer in an international multicentre\r\ncohort.” BJU international, 128 (2), 218-224N Almassi,\r\nEA Vertosick, DD Sjoberg, NC Wong, C Huang, EJ Pietzak,\r\nand others (2021). “Pathological and oncological outcomes in patients\r\nwith sarcomatoid differentiation undergoing cystectomy.” BJU\r\ninternational, J Coleman, DD Sjoberg, Q\r\nDemac, C Odea, M McGill, A Tracey, L Nogueira, and others (2021).\r\n“Results of the PCM-204 phase 2b trial of partial-gland ablation for men\r\nwith intermediate-risk prostate cancer with padeliporfin (WST11 or\r\nTOOKAD) vascular-targeted ….” Journal of Urology, e,\r\ne814-e815GT Chesnut, EA Vertosick, N Benfante, DD\r\nSjoberg, J Fainberg, T Lee, and others (2020). “Role of changes\r\nin magnetic resonance imaging or clinical stage in evaluation of disease\r\nprogression for men with prostate cancer on active surveillance.”\r\nEuropean urology, 77 (4), 501-507S Carlsson, N\r\nBenfante, R Alvim, DD Sjoberg, A Vickers, VE Reuter,\r\nand others (2020). “Long-term outcomes of active surveillance for\r\nprostate cancer: the Memorial Sloan Kettering Cancer Center experience.”\r\nThe Journal of urology, 203 (6), 1122-1127S Carlsson, N\r\nBenfante, R Alvim, DD Sjoberg, A Vickers, VE Reuter,\r\nand others (2020). “Risk of metastasis in men with grade group 2\r\nprostate cancer managed with active surveillance at a tertiary cancer\r\ncenter.” The Journal of urology, 203 (6), 1117-1121KA\r\nAmin, EA Vertosick, G Stearns, A Fathollahi, DD\r\nSjoberg, MS Donat, and others (2020). “Predictors of benign\r\nureteroenteric anastomotic strictures after radical cystectomy and\r\nurinary diversion.” Urology, 144, 225-229N Almassi, EK\r\nCha, EA Vertosick, C Huang, N Wong, S Dason, DD\r\nSjoberg, and others (2020). “Trends in management and outcomes\r\namong patients with urothelial carcinoma undergoing radical cystectomy\r\nfrom 1995 to 2015: the Memorial Sloan Kettering experience.” The\r\nJournal of Urology, 204 (4), 677-684EA Vertosick, C\r\nHäggström, DD Sjoberg, G Hallmans, R Johansson, and\r\nothers (2020). “Prespecified 4-Kallikrein marker model at age 50 or 60\r\nfor early detection of lethal prostate cancer in a large population\r\nbased cohort of asymptomatic men followed for 20 years.” The Journal\r\nof urology, 204 (2), 281-288A Vilaseca, G Guglielmetti, EA\r\nVertosick, DD Sjoberg, A Grasso, and others (2020).\r\n“Value of partial nephrectomy for renal cortical tumors of cT2 or\r\ngreater stage: a risk-benefit analysis of renal function preservation\r\nversus increased postoperative morbidity.” European urology\r\noncology, 3 (3), 365-371R Mano, EA Vertosick, J Sarcona,\r\nDD Sjoberg, NE Benfante, TF Donahue, and others (2020).\r\n“Primary urethral cancer: treatment patterns and associated outcomes..”\r\nBJU international, 126 (3), 359-366CA Bravi, A Tin, E\r\nVertosick, E Mazzone, M Bandini, P Dell’Oglio, DD\r\nSjoberg, and others (2020). “Androgen deprivation therapy in\r\nmen with node-positive prostate cancer treated with postoperative\r\nradiotherapy.” Urologic Oncology: Seminars and Original\r\nInvestigations, 38 (4), 204-209AJ Vickers, MJ Assel,\r\nDD Sjoberg, R Qin, Z Zhao, T Koyama, A Botchway, and\r\nothers (2020). “Guidelines for reporting of figures and tables for\r\nclinical research in urology.” The Journal of Urology, 204 (1),\r\n121-133JC Hu, B Ehdaie, J Sandhu, DD\r\nSjoberg, SV Carlsson, M Tzeng, and others (2020).\r\n“Asian-American race and urinary continence after radical\r\nprostatectomy.” European Urology Open Science, 22,\r\n51-53A Haese, AL Tin, SV Carlsson, DD\r\nSjoberg, D Pehrke, T Steuber, and others (2020). “A\r\npre-specified model based on four kallikrein markers in blood improves\r\npredictions of adverse pathology and biochemical recurrence after\r\nradical prostatectomy.” British journal of cancer, 123 (4),\r\n604-609GT Chesnut, P Zareba, DD Sjoberg, M\r\nMamoor, S Carlsson, T Lee, and others (2020). “Patient-reported pain,\r\ndiscomfort, and anxiety during magnetic resonance imaging-targeted\r\nprostate biopsy.” Canadian Urological Association Journal, 14 (5),\r\nE202W Li, M Bicak, DD Sjoberg, E\r\nVertosick, A Dahlin, O Melander, D Ulmert, and others (2020).\r\n“Genome-wide association study identifies novel single nucleotide\r\npolymorphisms having age-specific effect on prostate-specific antigen\r\nlevels.” The Prostate, 80 (16), 1405-1412S Dason, EK\r\nCha, C Falavolti, EA Vertosick, LW Dean, VA McPherson, DD\r\nSjoberg, and others (2020). “Late recurrences following radical\r\ncystectomy have distinct prognostic and management considerations.”\r\nThe Journal of urology, 204 (3), 460-465S Erestam, D\r\nBock, A Erichsen Andersson, A Bjartell, S Carlsson, DD\r\nSjoberg, and others (2020). “Associations between\r\nintraoperative factors and surgeons’ self-assessed operative\r\nsatisfaction.” Surgical endoscopy, 34 (1), 61-68GT\r\nChesnut, N Benfante, D Barham, LW Dean, A Tin, DD\r\nSjoberg, and others (2020). “Routine Postoperative Hemoglobin\r\nAssessment Poorly Predicts Transfusion Requirement among Patients\r\nUndergoing Minimally Invasive Radical Prostatectomy.” Urology\r\npractice, 7 (4), 299-304CA Bravi, G Rosiello, G Fallara, E\r\nVertosick, A Tin, DD Sjoberg, M Bianchi, and others\r\n(2020). “Predictive value of preoperative neutrophil-to-lymphocyte ratio\r\nin localized prostate cancer: results from a surgical series at a\r\nhigh-volume institution..” Minerva Urology and Nephrology, 73 (4),\r\n481-488KA Touijer, DD Sjoberg, N Benfante,\r\nNP Brau, IR Belenchón, CM Barrull, and others (2020). “Comparison of\r\nerectile function recovery between limited and extended pelvic lymph\r\nnode dissection for prostate cancer: Results from a large,\r\nclinically-integrated, randomized ….” European Urology Open Science,\r\n19, e2124CA Bravi, A Tin, E Vertosick, E Mazzone, M\r\nBandini, P Dell’Oglio, DD Sjoberg, and others (2020).\r\n“Relative contribution of androgen deprivation therapy in combination\r\nwith adjuvant radiotherapy for node-positive prostate cancer..”\r\nUrologic oncology, 38 (4), 204T Takeda, AL Tin, RB\r\nCorradi, R Alvim, T Hashimoto, Y Ito, DP Nguyen, DD\r\nSjoberg, and others (2020). “Extensive disease among potential\r\ncandidates for hemi-ablative focal therapy for prostate cancer.”\r\nInternational Journal of Urology, 27 (2), 179-185M\r\nAssel, DD Sjoberg, A Elders, X Wang, D Huo, A Botchway,\r\nK Delfino, and others (2019). “Guidelines for reporting of statistics\r\nfor clinical research in urology.” The Journal of urology, 201 (3),\r\n595-604CA Bravi, E Vertosick, N Benfante, A Tin, DD\r\nSjoberg, AA Hakimi, K Touijer, and others (2019). “Impact of\r\nacute kidney injury and its duration on long-term renal function after\r\npartial nephrectomy.” European urology, 76 (3),\r\n398-403LW Dean, M Assel, DD Sjoberg, AJ\r\nVickers, HA Al-Ahmadie, YB Chen, and others (2019). “Clinical usefulness\r\nof total length of Gleason pattern 4 on biopsy in men with grade group 2\r\nprostate cancer.” The Journal of urology, 201 (1),\r\n77-83MA Preston, T Gerke, SV Carlsson, L Signorello,\r\nDD Sjoberg, SC Markt, and others (2019). “Baseline\r\nprostate-specific antigen level in midlife and aggressive prostate\r\ncancer in black men.” European urology, 75 (3),\r\n399-407X Wu, H Scott, SV Carlsson, DD\r\nSjoberg, L Cerundolo, H Lilja, R Prevo, and others (2019).\r\n“Increased EZH2 expression in prostate cancer is associated with\r\nmetastatic recurrence following external beam radiotherapy.” The\r\nProstate, 79 (10), 1079-1089Y Ito, K Udo, EA Vertosick,\r\nDD Sjoberg, AJ Vickers, HA Al-Ahmadie, and others\r\n(2019). “Clinical usefulness of prostate and tumor volume related\r\nparameters following radical prostatectomy for localized prostate\r\ncancer.” The Journal of urology, 201 (3), 535-540P\r\nCapogrosso, EA Vertosick, NE Benfante, DD Sjoberg, AJ\r\nVickers, and others (2019). “Can we improve the preoperative prediction\r\nof prostate cancer recurrence with multiparametric MRI?.” Clinical\r\ngenitourinary cancer, 17 (4), e745-e750NC Wong, RG Alvim,\r\nDD Sjoberg, R Shingarev, NE Power, M Spaliviero, and\r\nothers (2019). “Phase III trial of intravenous mannitol versus placebo\r\nduring nephron-sparing surgery: Post hoc analysis of 3-yr outcomes.”\r\nEuropean Urology Focus, 5 (6), 977-979Y Ito, EA\r\nVertosick, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, YB\r\nChen, and others (2019). “In organ-confined prostate cancer, tumor\r\nquantitation not found to aid in prediction of biochemical recurrence.”\r\nThe American journal of surgical pathology, 43 (8),\r\n1061GT Chesnut, P Zareba, DD Sjoberg, M\r\nMamoor, S Carlsson, T Lee (2019). “Patient experience of MRI-targeted\r\nprostate biopsy Patient-reported pain, discomfort, and anxiety during\r\nmagnetic resonance imaging-targeted prostate biopsy.” Can Urol Assoc\r\nJ, 29M Assel, DD Sjoberg, JWF Catto, AJ\r\nVickers (2019). “Innovations in statistical review at European Urology.”\r\nEuropean urology, 75 (1), 1HL Bernie, B Nascimento, D\r\nKatz, A Tin, N Benfante, DD Sjoberg, and others (2019).\r\n“160 Predictors of Worsening Erectile Function in Men With Functional\r\nErections Early After Radical Prostatectomy.” The Journal of Sexual\r\nMedicine, 16 (4), S81B Nascimento, HL Bernie, H Taniguchi,\r\nEP Miranda, J Terrier, S Carlsson, DD Sjoberg, and\r\nothers (2019). “276 Baseline Characteristics of Treated and Untreated\r\nPatients with Peyronie’s Disease (PD).” The Journal of Sexual\r\nMedicine, 16 (4), S132S Fine, Y Ito, E Vertosick,\r\nDD Sjoberg, A Vickers, H Al-Ahmadie, YB Chen, and\r\nothers (2019). “In Organ-Confined Prostate Cancer at Radical\r\nProstatectomy, neither Total Tumor Volume nor Maximum Tumor Diameter of\r\nthe Index Lesion Aids in Prediction of Biochemical Recurrence.”\r\nLABORATORY INVESTIGATION, 99BH Bochner, G Dalbagni, KH\r\nMarzouk, DD Sjoberg, J Lee, SM Donat, and others\r\n(2018). “Randomized trial comparing open radical cystectomy and\r\nrobot-assisted laparoscopic radical cystectomy: oncologic outcomes.”\r\nEuropean urology, 74 (4), 465-471KA Touijer, RJ Karnes,\r\nN Passoni, DD Sjoberg, M Assel, N Fossati, and others\r\n(2018). “Survival outcomes of men with lymph node-positive prostate\r\ncancer after radical prostatectomy: a comparative analysis of different\r\npostoperative management strategies.” European urology, 73 (6),\r\n890-896M Nyberg, J Hugosson, P Wiklund, DD\r\nSjoberg, U Wilderäng, SV Carlsson, and others (2018).\r\n“Functional and oncologic outcomes between open and robotic radical\r\nprostatectomy at 24-month follow-up in the Swedish LAPPRO trial.”\r\nEuropean urology oncology, 1 (5), 353-360M Spaliviero,\r\nNE Power, KS Murray, DD Sjoberg, NE Benfante, and\r\nothers (2018). “Intravenous mannitol versus placebo during partial\r\nnephrectomy in patients with normal kidney function: a double-blind,\r\nclinically-integrated, randomized trial.” European urology, 73 (1),\r\n53-59W Li, M Middha, M Bicak, DD Sjoberg,\r\nE Vertosick, A Dahlin, and others (2018). “Genome-wide scan identifies\r\nrole for AOX1 in prostate cancer survival.” European urology, 74\r\n(6), 710-719AD Mally, AL Tin, JK Lee, P Satasivam, EK Cha,\r\nSM Donat, HW Herr, DD Sjoberg, and others (2018).\r\n“Clinical outcomes of patients with T1 nested variant of urothelial\r\ncarcinoma compared to pure urothelial carcinoma of the bladder.”\r\nClinical genitourinary cancer, 16 (1), e23-e27EK Cha,\r\nJP Sfakianos, R Sukhu, AM Yee, DD Sjoberg, BH Bochner\r\n(2018). “Poor prognosis of bladder cancer patients with occult lymph\r\nnode metastases treated with neoadjuvant chemotherapy.” BJU\r\ninternational, 122 (4), 627E Kovac, EA Vertosick,\r\nDD Sjoberg, AJ Vickers, AJ Stephenson (2018). “Effects\r\nof Pathologic Upstaging or Upgrading on Metastasis and Cancer-Specific\r\nMortality in men with Clinical Low-risk Prostate Cancer.” BJU\r\ninternational, 122 (6), 1003DP Nguyen, EA Vertosick, V\r\nSharma, RB Corradi, A Vilaseca, T Takeda, DD Sjoberg,\r\nand others (2018). “Does subclassification of pathologically organ\r\nconfined (pT2) prostate cancer provide prognostic discrimination of\r\noutcomes after radical prostatectomy?.” The Journal of urology, 199\r\n(6), 1502-1509RG Alvim, F Audenet, EA Vertosick, DD\r\nSjoberg, KA Touijer (2018). “Performance prediction for\r\nsurgical outcomes in partial nephrectomy using nephrometry scores: a\r\ncomparison of Arterial Based Complexity (ABC), RENAL, and PADUA\r\nsystems.” European Urology Oncology, 1 (5), 428-434T\r\nTakeda, AL Tin, RB Corradi, M Mamoor, NE Benfante, DD\r\nSjoberg, and others (2018). “Topography of prostate cancer\r\nrecurrence after radiation therapy: a detailed mapping study of salvage\r\nradical prostatectomy specimens.” European urology, 73 (4),\r\n488-490K Marzouk, A Tin, N Liu, DD\r\nSjoberg, AA Hakimi, P Russo, J Coleman (2018). “The natural\r\nhistory of large renal masses followed on observation.” Urologic\r\nOncology: Seminars and Original Investigations, 36 (8), 362.\r\ne17-362 …M Rieken, LA Kluth, H Fajkovic, U Capitanio, A\r\nBriganti, LM Krabbe, DD Sjoberg, and others (2018).\r\n“Predictors of cancer-specific survival after disease recurrence in\r\npatients with renal cell carcinoma: the effect of time to recurrence.”\r\nClinical genitourinary cancer, 16 (4), e903-e908AJ\r\nVickers, EA Vertosick, DD Sjoberg (2018). “Value of a\r\nstatistical model based on four kallikrein markers in blood,\r\ncommercially available as 4Kscore, in all reasonable prostate biopsy\r\nsubgroups.” European urology, 74 (4), 535P Capogrosso,\r\nA Larcher, DD Sjoberg, EA Vertosick, F Cianflone, and\r\nothers (2018). “Risk based surveillance after surgical treatment of\r\nrenal cell carcinoma.” The Journal of urology, 200 (1),\r\n61-67L Marconi, R de Bruijn, E van Werkhoven, C Beisland, K\r\nFife, DD Sjoberg, and others (2018). “External\r\nvalidation of a predictive model of survival after cytoreductive\r\nnephrectomy for metastatic renal cell carcinoma.” World journal of\r\nurology, 36 (12), 1973-1980CM Dowling, M Assel, JE Musser,\r\nJJ Meeks, DD Sjoberg, G Bosl, and others (2018).\r\n“Clinical outcome of retroperitoneal lymph node dissection after\r\nchemotherapy in patients with pure embryonal carcinoma in the\r\norchiectomy specimen.” Urology, 114, 133-138A Bagrodia,\r\nR Sukhu, AG Winer, E Levy, M Vacchio, B Lee, EJ Pietzak, DD\r\nSjoberg, and others (2018). “Incidence and effect of\r\nthromboembolic events in radical cystectomy patients undergoing\r\npreoperative chemotherapy for muscle-invasive bladder cancer.”\r\nClinical genitourinary cancer, 16 (1), e113-e120JK Lee,\r\nDD Sjoberg, MI Miller, AJ Vickers, JP Mulhall, B Ehdaie\r\n(2018). “Improved recovery of erectile function in younger men after\r\nradical prostatectomy: Does it justify immediate surgery in low-risk\r\npatients?.” European urology, 73 (1), 33-37M Ghanaat,\r\nAG Winer, DD Sjoberg, BY Poon, M Kashan, AL Tin, and\r\nothers (2018). “Comparison of postradical cystectomy ileus rates using\r\nGIA-80 versus GIA-60 intestinal stapler device.” Urology, 122,\r\n121-126A Vickers, EA Vertosick, DD\r\nSjoberg, F Hamdy, D Neal, A Bjartell, and others (2018). “Value\r\nof intact prostate specific antigen and human kallikrein 2 in the 4\r\nkallikrein predictive model: an individual patient data meta-analysis.”\r\nThe Journal of urology, 199 (6), 1470-1474KS Murray, EA\r\nVertosick, M Spaliviero, JW Mashni Jr, DD Sjoberg, and\r\nothers (2018). “Importance of wide re-resection in adult spermatic cord\r\nsarcomas: Report on oncologic outcomes at a single institution.”\r\nJournal of surgical oncology, 117 (7), 1464-1468F\r\nAudenet, EA Vertosick, SW Fine, DD Sjoberg, AJ Vickers,\r\nVE Reuter, and others (2018). “Biopsy core features are poor predictors\r\nof adverse pathology in men with grade group 1 prostate cancer.” The\r\nJournal of urology, 199 (4), 961-968K Lapen, L Benusis, S\r\nPearson, B Search, M Coleton, QS Li, DD Sjoberg, and\r\nothers (2018). “A feasibility study of restorative yoga versus vigorous\r\nyoga intervention for sedentary breast and ovarian cancer survivors.”\r\nInternational journal of yoga therapy, 28 (1), 79-85EJ\r\nPietzak, M Assel, MF Becerra, D Tennenbaum, DR Feldman, DD\r\nSjoberg, and others (2018). “Histologic and oncologic outcomes\r\nfollowing liver mass resection with retroperitoneal lymph node\r\ndissection in patients with nonseminomatous germ cell tumor.”\r\nUrology, 118, 114-118AE Thong, BY Poon, JK Lee, E\r\nVertosick, DD Sjoberg, AJ Vickers, and others (2018).\r\n“Concordance between patient-reported and physician-reported sexual\r\nfunction after radical prostatectomy.” Urologic Oncology: Seminars\r\nand Original Investigations, 36 (2), 80. e1-80. e6Y Ito, K\r\nUdo, EA Vertosick, DD Sjoberg, AJ Vickers, HA\r\nAl-Ahmadie, and others (2018). “Clinical utility of prostate and tumor\r\nvolume-related parameters following radical prostatectomy for localized\r\nprostate cancer.” The Journal of Urology, LW Dean, M\r\nAssel, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, YB Chen,\r\nand others (2018). “Clinical utility of total length Gleason pattern 4\r\non biopsy in men with grade group 2 prostate cancer.” J Urol,\r\n10E Kovac, EA Vertosick, DD Sjoberg, AJ\r\nVickers, AJ Stephenson (2018). “Re: Effects of Pathological Upstaging or\r\nUpgrading on Metastasis and Cancer-Specific Mortality in Men with\r\nClinical Low-Risk Prostate Cancer Editorial Comment.” JOURNAL OF\r\nUROLOGY, 200 (5), 945-946AJ Vickers, H Lilja, Y Dong,\r\nDD Sjoberg, PT Scardino (2018). “Composiciones y\r\nmétodos para la vigilancia activa del cáncer de próstata..” ,\r\nY Dong, AJ Vickers, DD Sjoberg, PT\r\nScardino, H Lilja (2018). “Composiciones y metodos para la vigilancia\r\nactiva del cancer de prostata.” , H Lilja, PT Scardino,\r\nAJ Vickers, Y Dong, DD Sjoberg (2018). “Sistemas y\r\nmétodos para la vigilancia activa del cancer de próstata.” ,\r\nNT John, A Tin, RG Dinatale, NE Benfante, DD\r\nSjoberg, AA Hakimi, and others (2018). “Genomic Predictors of\r\nResponse to Neoadjuvant Cisplatin-based Chemotherapy in Upper Tract\r\nUrothelial Carcinoma (UTUC).” JOURNAL OF UROLOGY, 199 (4),\r\nE216-E216NT John, A Tin, DD Sjoberg, N\r\nBenfante, AA Hakimi, P Russo, J Coleman (2018). “Can Imaging Response\r\nfollowing Neoadjuvant Chemotherapy in Upper Tract Urothelial Cancer be a\r\nSurrogate for Pathologic Response?.” JOURNAL OF UROLOGY, 199 (4),\r\nE214-E215SW Fine, H Al-Ahmadie, E Vertosick, DD\r\nSjoberg, A Vickers, YB Chen, and others (2018). “Impact of Zone\r\nof Origin in Anterior-Dominant Prostatic Tumors: Long-Term Biochemical\r\nRecurrence-Free Survival in an Anatomically Well-Annotated Series.”\r\nLABORATORY INVESTIGATION, 98, 340-340DW Lin, LF\r\nNewcomb, MD Brown, DD Sjoberg, Y Dong, JD Brooks, and\r\nothers (2017). “Evaluating the four kallikrein panel of the 4Kscore for\r\nprediction of high-grade prostate cancer in men in the Canary Prostate\r\nActive Surveillance Study.” European urology, 72 (3),\r\n448-454K Mooney, DL Berry, M Whisenant, DD\r\nSjoberg (2017). “Improving cancer care through the patient\r\nexperience: how to use patient-reported outcomes in clinical practice.”\r\nAmerican Society of Clinical Oncology Educational Book, 37,\r\n695-704MJ O’Shaughnessy, SM McBride, HA Vargas, KA Touijer,\r\nMJ Morris, DD Sjoberg, and others (2017). “A pilot\r\nstudy of a multimodal treatment paradigm to accelerate drug evaluations\r\nin early-stage metastatic prostate cancer.” Urology, 102,\r\n164-172M Assel, DD Sjoberg, AJ Vickers\r\n(2017). “The Brier score does not evaluate the clinical utility of\r\ndiagnostic tests or prediction models.” Diagnostic and prognostic\r\nresearch, 1 (1), 1-7R Chen, DD Sjoberg, Y\r\nHuang, L Xie, L Zhou, D He, AJ Vickers, Y Sun (2017). “Prostate specific\r\nantigen and prostate cancer in Chinese men undergoing initial prostate\r\nbiopsies compared with Western cohorts.” The Journal of urology, 197\r\n(1), 90-96BJ Manley, DM Tennenbaum, EA Vertosick, JJ Hsieh,\r\nDD Sjoberg, and others (2017). “The difficulty in\r\nselecting patients for cytoreductive nephrectomy: an evaluation of\r\npreviously described predictive models.” Urologic Oncology: Seminars\r\nand Original Investigations, 35 (1), 35. e1-35. e5EH Kim,\r\nGL Andriole, ED Crawford, DD Sjoberg, M Assel, AJ\r\nVickers, and others (2017). “Detection of high grade prostate cancer\r\namong PLCO participants using a prespecified 4-kallikrein marker panel.”\r\nThe Journal of urology, 197 (4), 1041-1047A Vickers, EA\r\nVertosick, DD Sjoberg, MJ Roobol, F Hamdy, D Neal, and\r\nothers (2017). “Properties of the 4-kallikrein panel outside the\r\ndiagnostic gray zone: meta-analysis of patients with positive digital\r\nrectal examination or prostate specific antigen 10 ng/ml ….” The\r\nJournal of urology, 197 (3), 607-613SM Zappala, Y Dong, V\r\nLinder, M Reeve, DD Sjoberg, V Mathur, and others\r\n(2017). “The 4Kscore blood test accurately identifies men with\r\naggressive prostate cancer prior to prostate biopsy with or without DRE\r\ninformation.” International journal of clinical practice, 71 (6),\r\ne12943S Punnen, B Nahar, NS Prakash, DD\r\nSjoberg, SM Zappala, DJ Parekh (2017). “The 4Kscore predicts\r\nthe grade and stage of prostate cancer in the radical prostatectomy\r\nspecimen: results from a multi-institutional prospective trial.”\r\nEuropean urology focus, 3 (1), 94-99A Vilaseca, DP\r\nNguyen, EA Vertosick, RB Corradi, M Musquera, M Pérez, DD\r\nSjoberg, and others (2017). “Obstructive sleep apnea and\r\nFuhrman grade in patients with clear cell renal cell carcinoma treated\r\nsurgically.” World journal of urology, 35 (1), 51-56RB\r\nCorradi, EA Vertosick, DP Nguyen, A Vilaseca, DD\r\nSjoberg, and others (2017). “Nephrometry scores and\r\nperioperative outcomes following robotic partial nephrectomy.”\r\nInternational braz j urol, 43, 1075-1083A Polland, EA\r\nVertosick, DD Sjoberg, GL Stearns, LS Leddy, and others\r\n(2017). “Preoperative symptoms predict continence after post-radiation\r\ntransurethral resection of prostate..” The Canadian Journal of\r\nUrology, 24 (4), 8903-8909AG Winer, EA Vertosick, M\r\nGhanaat, RB Corradi, S Carlsson, DD Sjoberg, and others\r\n(2017). “Prognostic value of lymph node yield during nephroureterectomy\r\nfor upper tract urothelial carcinoma.” Urologic Oncology: Seminars\r\nand Original Investigations, 35 (4), 151. e9-151. e15G\r\nDalbagni, N Benfante, DD Sjoberg, BH Bochner, S Machele\r\nDonat, and others (2017). “Single arm phase I/II study of everolimus and\r\nintravesical gemcitabine in patients with primary or secondary carcinoma\r\nin situ of the bladder who failed bacillus Calmette ….” Bladder\r\nCancer, 3 (2), 113-119Y Dong, AJ Vickers, DD\r\nSjoberg, PT Scardino, H Lilja (2017). “Compositions and methods\r\nfor active surveillance of prostate cancer.” US Patent App.,\r\n15/143,345DP Nguyen, M Kent, A Vilaseca, RB Corradi, N\r\nFossati, DD Sjoberg, and others (2017). “Updated\r\npostoperative nomogram incorporating the number of positive lymph nodes\r\nto predict disease recurrence following radical prostatectomy.”\r\nProstate Cancer and Prostatic Diseases, 20 (1),\r\n105-109LH Rosenberger, R Weber, DD\r\nSjoberg, AJ Vickers, DA Mangino, and others (2017). “Impact of\r\nself-reported data on the acquisition of multi-generational family\r\nhistory and lifestyle factors among women seen in a high-risk breast\r\nscreening program: a focus on ….” Breast cancer research and\r\ntreatment, 162 (2), 275-282JI Epstein, MJ Zelefsky,\r\nDD Sjoberg, JB Nelson, L Egevad, and others (2016). “A\r\ncontemporary prostate cancer grading system: a validated alternative to\r\nthe Gleason score.” European urology, 69 (3), 428-435K\r\nBraun, DD Sjoberg, AJ Vickers, H Lilja, AS Bjartell\r\n(2016). “A four-kallikrein panel predicts high-grade cancer on biopsy:\r\nindependent validation in a community cohort.” European urology, 69\r\n(3), 505-511M Spaliviero, BY Poon, CA Karlo, GB\r\nGuglielmetti, PL Di Paolo, DD Sjoberg, and others\r\n(2016). “An arterial based complexity (ABC) scoring system to assess the\r\nmorbidity profile of partial nephrectomy.” European urology, 69 (1),\r\n72-79P Recabal, M Assel, DD Sjoberg, D\r\nLee, VP Laudone, K Touijer, and others (2016). “The efficacy of\r\nmultiparametric magnetic resonance imaging and magnetic resonance\r\nimaging targeted biopsy in risk classification for patients with\r\nprostate cancer on active ….” The Journal of urology, 196 (2),\r\n374-381DP Nguyen, EA Vertosick, RB Corradi, A Vilaseca, NE\r\nBenfante, DD Sjoberg, and others (2016). “Histological\r\nsubtype of renal cell carcinoma significantly affects survival in the\r\nera of partial nephrectomy.” Urologic Oncology: Seminars and\r\noriginal investigations, 34 (6), 259. e1-259. e8M Imnadze,\r\nDD Sjoberg, AJ Vickers (2016). “Adverse pathologic\r\nfeatures at radical prostatectomy: effect of preoperative risk on\r\noncologic outcomes.” European urology, 69 (1), 143-148C\r\nAnderson, R Weber, D Patel, W Lowrance, A Mellis, M Cookson, DD\r\nSjoberg, and others (2016). “A 10-item checklist improves\r\nreporting of critical procedural elements during transurethral resection\r\nof bladder tumor.” The Journal of urology, 196 (4),\r\n1014-1020DJ Lee, P Recabal, DD Sjoberg, A\r\nThong, JK Lee, JA Eastham, and others (2016). “Comparative effectiveness\r\nof targeted prostate biopsy using magnetic resonance imaging ultrasound\r\nfusion software and visual targeting: a prospective study.” The\r\nJournal of Urology, 196 (3), 697-702CD Jakubowski, EA\r\nVertosick, BR Untch, DD Sjoberg, E Wei, FL Palmer, and\r\nothers (2016). “Complete metastasectomy for renal cell carcinoma:\r\ncomparison of five solid organ sites.” Journal of surgical oncology,\r\n114 (3), 375-379A Sankin, AL Tin, R Mano, M Chevinsky, C\r\nJakubowski, JP Sfakianos, DD Sjoberg, and others\r\n(2016). “Impact of ureteroscopy before nephroureterectomy for upper\r\ntract urothelial carcinoma on oncologic outcomes.” Urology, 94,\r\n148-153N Fossati, NM Passoni, M Moschini, G Gandaglia, A\r\nLarcher, M Freschi, DD Sjoberg, and others (2016).\r\n“Impact of stage migration and practice changes on high risk prostate\r\ncancer: results from patients treated with radical prostatectomy over\r\nthe last two decades.” BJU international, 117 (5), 740R\r\nMano, EA Vertosick, AA Hakimi, IA Sternberg, DD\r\nSjoberg, M Bernstein, and others (2016). “The effect of\r\ndelaying nephrectomy on oncologic outcomes in patients with renal tumors\r\ngreater than 4 cm.” Urologic Oncology: Seminars and Original\r\nInvestigations, 34 (5), 239. e1-239. e8LV Selby, M Sovel,\r\nDD Sjoberg, M McSweeney, D Douglas, DR Jones, and\r\nothers (2016). “Preoperative chemoprophylaxis is safe in major oncology\r\noperations and effective at preventing venous thromboembolism.”\r\nJournal of the American College of Surgeons, 222 (2),\r\n129-137WM Bazzi, AL Tin, DD Sjoberg, M\r\nBernstein, P Russo (2016). “The prognostic utility of preoperative\r\nneutrophil-to-lymphocyte ratio in localized clear cell renal cell\r\ncarcinoma.” The Canadian journal of urology, 23 (1),\r\n8151NW Liu, JD Wren, E Vertosick, JK Lee, NE Power, NE\r\nBenfante, SY Kimm, DD Sjoberg, and others (2016). “The\r\nprognostic impact of a positive vascular margin on pT3 clear cell renal\r\ncell carcinoma.” The Journal of urology, 195 (2),\r\n264-269A Ronnblom, T Holmstrom, H Tanghoj, U Karlbom, M\r\nThorn, DD Sjoberg (2016). “Low colectomy rate five\r\nyears after diagnosis of ulcerative colitis. Results from a prospective\r\npopulation-based cohort in Sweden (ICURE) diagnosed during 2005-2009.”\r\nScandinavian journal of gastroenterology, 51 (11),\r\n1339-1344A Rönnblom, T Holmström, H Tanghöj, U Karlbom, M\r\nThörn, D Sjöberg (2016). “Low colectomy rate five years after diagnosis\r\nof ulcerative colitis. Results from a prospective population-based\r\ncohort in Sweden (ICURE) diagnosed during 2005–2009.” Scandinavian\r\nJournal of Gastroenterology, 51 (11), 1339-1344P Recabal, M\r\nAssel, JE Musser, RJ Caras, DD Sjoberg, JA Coleman, and\r\nothers (2016). “Erectile function recovery after radical prostatectomy\r\nin men with high risk features.” The Journal of urology, 196 (2),\r\n507-513DP Nguyen, A Vilaseca, EA Vertosick, RB Corradi, KA\r\nTouijer, DD Sjoberg, and others (2016). “Histologic\r\nsubtype impacts cancer-specific survival in patients with\r\nsarcomatoid-variant renal cell carcinoma treated surgically.” World\r\njournal of urology, 34 (4), 539-544B Ehdaie, BY Poon,\r\nDD Sjoberg, P Recabal, V Laudone, K Touijer, and others\r\n(2016). “Variation of serum prostate-specific antigen in men with\r\nprostate cancer managed with active surveillance.” BJU\r\ninternational, 118 (4), 535DJ Lee, P Recabal, DD\r\nSjoberg, A Thong, JK Lee, JA Eastham, and others (2016).\r\n“Comparative effectiveness of targeted prostate biopsy using MRI-US\r\nfusion software and visual targeting: a prospective study.” The\r\nJournal of urology, 196 (3), 697CB Anderson, AL Tin,\r\nDD Sjoberg, JP Mulhall, J Sandhu, VP Laudone, and\r\nothers (2016). “Association between number of prostate biopsies and\r\npatient-reported functional outcomes after radical prostatectomy:\r\nimplications for active surveillance protocols.” BJU international,\r\n117 (6B), E46G Gugliemetti, R Sukhu, MAC Baenas, J Meeks,\r\nDD Sjoberg, JA Eastham, and others (2016). “Number of\r\nmetastatic lymph nodes as determinant of outcome after salvage radical\r\nprostatectomy for radiation-recurrent prostate cancer.” Actas\r\nUrológicas Españolas (English Edition), 40 (7), 434-439P\r\nRecabal, M Assel, DD Sjoberg, D Lee, VP Laudone, K\r\nTouijer, and others (2016). “The efficacy of multiparametric magnetic\r\nresonance imaging and MRI-targeted biopsy in risk classification for\r\npatients with prostate cancer on active surveillance.” The Journal\r\nof urology, 196 (2), 374Y Dong, AJ Vickers, DD\r\nSjoberg, PT Scardino, H Lilja (2016). “Compositions and methods\r\nfor active surveillance of prostate cancer.” US Patent App.,\r\n15/143,329MA Feuerstein, JE Musser, M Kent, M Chevinsky, EK\r\nCha, S Kimm, DD Sjoberg, and others (2016). “Low yield\r\nof surveillance imaging after surgery for T1 kidney cancer.” World\r\njournal of urology, 34 (7), 949-953A Vilaseca Cabo, D\r\nNguyen, A Tin, R Corradi, A Martin-Malburet, DD\r\nSjoberg, and others (2016). “433 Long-term oncological outcomes\r\nof salvage radical prostatectomy for radio-recurrent/persistent prostate\r\ncancer after radiation therapy.” EUROPEAN UROLOGY-SUPPLEMENTS-, 15\r\n(3), e433-e433G Gugliemetti, R Sukhu, MAC Baenas, J Meeks,\r\nDD Sjoberg, JA Eastham, and others (2016). “Número de\r\nganglios linfáticos metastásicos como determinante de los resultados de\r\nla prostatectomía radical de rescate en el cáncer de próstata de\r\nrecidivante tras radioterapia.” Actas urologicas espanolas, 40 (7),\r\n434-439D Lin, M Brown, L Newcomb, DD\r\nSjoberg, J Brooks, P Carroll, A Dash, and others (2016).\r\n“PD08-02 evaluating the four kallikrein panel of the 4kscore for\r\nprediction of high-grade prostate cancer in men in the canary prostate\r\nactive surveillance study (PASS).” The Journal of Urology, 195 (4S),\r\ne229-e229Y Dong, AJ Vickers, DD Sjoberg,\r\nPT Scardino, H Lilja (2016). “Compositions and methods for active\r\nsurveillance of prostate cancer.” , J Epstein, MJ\r\nZelefsky, DD Sjoberg, JB Nelson, L Egevad, and others\r\n(2016). “A Contemporary Prostate Cancer Grading System: A Validated\r\nAlternative to the Gleason Score (Retraction of Vol 69, Pg 428, 2016).”\r\nPATHOLOGY INTERNATIONAL, 66 (10), 600-+M Imnadze,\r\nDD Sjoberg, J Lee, LC Jenkins, A Vickers, JP Mulhall, B\r\nEhdaie (2016). “050 Improved Recovery of Erectile Function in Younger\r\nMen after Radical Prostatectomy: Does it Justify Immediate Intervention\r\nin Low-Risk Patients?.” The Journal of Sexual Medicine, 13 (5),\r\nS24D Siemens, H Klotz, A Heidenreich, S Chowdhury, A\r\nVillers, B Baron, DD Sjoberg, and others (2016).\r\n“Podium Session 1: Prostate Cancer June 26, 2016 1050–1150.”\r\nCanadian Urological Association Journal= Journal de L’association\r\ndes …, BH Bochner, G Dalbagni, DD Sjoberg,\r\nJ Silberstein, GEK Paz, SM Donat, and others (2015). “Comparing open\r\nradical cystectomy and robot-assisted laparoscopic radical cystectomy: a\r\nrandomized clinical trial.” European urology, 67 (6),\r\n1042-1050DJ Parekh, S Punnen, DD Sjoberg,\r\nSW Asroff, JL Bailen, JS Cochran, and others (2015). “A\r\nmulti-institutional prospective trial in the USA confirms that the\r\n4Kscore accurately identifies men with high-grade prostate cancer.”\r\nEuropean urology, 68 (3), 464-470RJ Bryant, DD\r\nSjoberg, AJ Vickers, MC Robinson, R Kumar, L Marsden, and\r\nothers (2015). “Predicting high-grade cancer at ten-core prostate biopsy\r\nusing four kallikrein markers measured in blood in the ProtecT study.”\r\nJNCI: Journal of the National Cancer Institute, 107\r\n(7)P Stattin, AJ Vickers, DD Sjoberg, R\r\nJohansson, T Granfors, M Johansson, and others (2015). “Improving the\r\nspecificity of screening for lethal prostate cancer using\r\nprostate-specific antigen and a panel of kallikrein markers: a nested\r\ncase–control study.” European urology, 68 (2),\r\n207-213AJ Vickers, DD Sjoberg (2015).\r\n“Guidelines for reporting of statistics in European Urology.” Eur\r\nUrol, 67 (2), 181-187LV Selby, EA Vertosick, DD\r\nSjoberg, MA Schattner, YY Janjigian, and others (2015).\r\n“Morbidity after total gastrectomy: analysis of 238 patients.”\r\nJournal of the American College of Surgeons, 220 (5), 863-871.\r\ne2JK Lee, M Assel, AE Thong, DD Sjoberg,\r\nJP Mulhall, J Sandhu, and others (2015). “Unexpected long-term\r\nimprovements in urinary and erectile function in a large cohort of men\r\nwith self-reported outcomes following radical prostatectomy.”\r\nEuropean urology, 68 (5), 899-905M Spaliviero, BY Poon,\r\nO Aras, PL Di Paolo, GB Guglielmetti, DD Sjoberg, and\r\nothers (2015). “Interobserver variability of RENAL, PADUA, and\r\ncentrality index nephrometry score systems.” World journal of\r\nurology, 33 (6), 853-858KM Wesa, NH Segal, AM Cronin,\r\nDD Sjoberg, GN Jacobs, MI Coleton, and others (2015).\r\n“Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer:\r\na retrospective analysis.” Nutrition and cancer, 67 (3),\r\n424-430M Chevinsky, M Imnadze, A Sankin, A Winer, R Mano, C\r\nJakubowski, DD Sjoberg, and others (2015).\r\n“Pathological stage T3a significantly increases disease recurrence\r\nacross all tumor sizes in renal cell carcinoma.” The Journal of\r\nurology, 194 (2), 310-315WM Bazzi, DD\r\nSjoberg, MA Feuerstein, A Maschino, S Verma, and others (2015).\r\n“Long-term survival rates after resection for locally advanced kidney\r\ncancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.”\r\nThe Journal of urology, 193 (6), 1911-1917R Mano, M\r\nKent, Y Larish, AG Winer, MS Chevinsky, AA Hakimi, DD\r\nSjoberg, and others (2015). “Partial and radical nephrectomy\r\nfor unilateral synchronous multifocal renal cortical tumors.”\r\nUrology, 85 (6), 1404-1410CB Anderson, IA Sternberg, G\r\nKaren-Paz, PH Kim, DD Sjoberg, HA Vargas, and others\r\n(2015). “Age is associated with upgrading at confirmatory biopsy among\r\nmen with prostate cancer treated with active surveillance.” The\r\nJournal of Urology, 194 (6), 1607-1611JL Silberstein, SA\r\nPoon, DD Sjoberg, AC Maschino, AJ Vickers, A Bernie,\r\nand others (2015). “Long term oncologic outcomes of a Phase II trial of\r\nneoadjuvant chemohormonal therapy followed by radical prostatectomy for\r\npatients with clinically localized, high-risk ….” BJU international,\r\n116 (1), 50TP Ghoneim, DD Sjoberg, W\r\nLowrance, SF Shariat, C Savage, and others (2015). “Partial nephrectomy\r\nfor renal tumors in solitary kidneys: postoperative renal function\r\ndynamics.” World journal of urology, 33 (12),\r\n2023-2029R Mano, E Vertosick, AI Sankin, MS Chevinsky, Y\r\nLarish, CD Jakubowski, DD Sjoberg, and others (2015).\r\n“Subcentimeter pulmonary nodules are not associated with disease\r\nprogression in patients with renal cell carcinoma.” The Journal of\r\nurology, 193 (3), 776-782T Gondo, BY Poon, K Matsumoto, M\r\nBernstein, DD Sjoberg, JA Eastham (2015). “Clinical\r\nrole of pathological downgrading after radical prostatectomy in patients\r\nwith biopsy-proven Gleason score 3+ 4 prostate cancer.” BJU\r\ninternational, 115 (1), 81WM Bazzi, DD\r\nSjoberg, AAC Grasso, M Bernstein, R Parra, JA Coleman (2015).\r\n“Predicting length of stay after robotic partial nephrectomy.”\r\nInternational urology and nephrology, 47 (8),\r\n1321-1325LV Selby, DD Sjoberg, D Cassella,\r\nM Sovel, MR Weiser, K Sepkowitz, and others (2015). “Comparing surgical\r\ninfections in national surgical quality improvement project and an\r\ninstitutional database.” Journal of Surgical Research, 196 (2),\r\n416-420WM Bazzi, LY Chen, BH Cordon, J Mashni, DD\r\nSjoberg, M Bernstein, and others (2015). “Non-neoplastic\r\nparenchymal changes in kidney cancer and post-partial nephrectomy\r\nrecovery of renal function.” International urology and nephrology,\r\n47 (9), 1499-1502N Fossati, A Larcher, GM Gadda, DD\r\nSjoberg, FA Mistretta, P Dell’Oglio, and others (2015).\r\n“Minimally invasive partial nephrectomy versus laparoscopic cryoablation\r\nfor patients newly diagnosed with a single small renal mass.”\r\nEuropean Urology Focus, 1 (1), 66-72JE Musser, MJ\r\nAssel, JJ Meeks, DD Sjoberg, AJ Vickers, JA Coleman,\r\nand others (2015). “Ambulatory extended recovery: safely transitioning\r\nto overnight observation for minimally invasive prostatectomy.”\r\nUrology Practice, 2 (3), 121-125N Fossati, DD\r\nSjoberg, U Capitanio, G Gandaglia, A Larcher, A Nini, and\r\nothers (2015). “Extended pelvic lymph node dissection in patients with\r\nprostate cancer previously treated with surgery for lower urinary tract\r\nsymptoms.” BJU international, 116 (3), 366-372M\r\nCesarini, G Collins, A Ronnblom, A Santos, DD Sjoberg,\r\nM Parkes, and others (2015). “Predicting the risk of acute severe\r\ncolitis (ASC) at diagnosis of Ulcerative Colitis (UC): external\r\nvalidation.” Journal of Crohn’s and Colitis, 9 (suppl\r\n1)C Eriksson, S Almer, JA Bjork, M Eberhardson, A Eriksson,\r\nO Grip, DD Sjoberg, and others (2015). “Vedolizumab in\r\ninflammatory bowel disease, the first experience from the Swedish IBD\r\nRegistry (SWIBREG).” Gastroenterology, 148 (4),\r\nS871-S871S Punnen, S Zappala, J Palou, DD\r\nSjoberg, V Mathur, R Roberts, V Vincent, and others (2015).\r\n“433 Among men with low-grade prostate cancer on prostate biopsy, the\r\n4Kscore predicts the presence of more aggressive prostate cancer.”\r\nEuropean urology supplements: official journal of the European\r\nAssociation …, AJ Vickers, DD Sjoberg\r\n(2015). “Decision analysis of dutasteride use for patients with negative\r\nprostate biopsy.” Urology, 85 (2), 337-342A Bondarik, D\r\nSjöberg (2015). “Implementation of UC-EBG structure for 60 GHz gridded\r\nparasitic patch stacked microstrip antenna.” , 2015 9th European\r\nConference on Antennas and Propagation (EuCAP), 1-5S\r\nPunnen, DD Sjoberg, SM Zappala, D Parekh (2015). “A\r\nmulti-institutional prospective trial in the United States to confirm\r\nthe 4Kscore identification of men with high-grade prostate cancer.”\r\nJOURNAL OF CLINICAL ONCOLOGY, 33 (7)JL Silberstein, SA\r\nPoon, DD Sjoberg (2015). “Neoadjuvante\r\nChemohormontherapie vor radikaler Prostatektomie?.” Urologie Scan, 2\r\n(04), 251-251BH Bochner, G Dalbagni, DD\r\nSjoberg (2015). “Offen chirurgische versus roboterassistierte\r\nlaparoskopische radikale Zystektomie.” Urologie Scan, 2 (04),\r\n247-247N Power, C Willie, C Mazzola, T Tailly, E Sonke, S\r\nPardhan, A Tram, DD Sjoberg, and others (2015). “2015\r\nCUA Abstracts.” Canadian Urological Association Journal= Journal de\r\nL’association des …, EK Bancroft, EC Page, E Castro, H\r\nLilja, A Vickers, DD Sjoberg, M Assel, and others\r\n(2014). “Targeted prostate cancer screening in BRCA1 and BRCA2 mutation\r\ncarriers: results from the initial screening round of the IMPACT study.”\r\nEuropean urology, 66 (3), 489-499KA Touijer, CR\r\nMazzola, DD Sjoberg, PT Scardino, JA Eastham (2014).\r\n“Long-term outcomes of patients with lymph node metastasis treated with\r\nradical prostatectomy without adjuvant androgen-deprivation therapy.”\r\nEuropean urology, 65 (1), 20-25S Carlsson, M Assel,\r\nDD Sjoberg, D Ulmert, J Hugosson, H Lilja, A Vickers\r\n(2014). “Influence of blood prostate specific antigen levels at age 60\r\non benefits and harms of prostate cancer screening: population based\r\ncohort study.” Bmj, 348AJ Vickers, DD\r\nSjoberg, D Ulmert, E Vertosick, MJ Roobol, I Thompson, and\r\nothers (2014). “Empirical estimates of prostate cancer overdiagnosis by\r\nage and prostate-specific antigen.” BMC medicine, 12 (1),\r\n1-7BH Bochner, DD Sjoberg, VP Laudone\r\n(2014). “A randomized trial of robot-assisted laparoscopic radical\r\ncystectomy.” New England journal of medicine, 371 (4),\r\n389-390M Spaliviero, G Dalbagni, BH Bochner, BY Poon, H\r\nHuang, DD Sjoberg, and others (2014). “Clinical outcome\r\nof patients with T1 micropapillary urothelial carcinoma of the bladder.”\r\nThe Journal of urology, 192 (3), 702-707K Braun, Y\r\nAhallal, DD Sjoberg, T Ghoneim, M Dominguez Esteban,\r\nand others (2014). “Effect of repeated prostate biopsies on erectile\r\nfunction in men on active surveillance for prostate cancer.” The\r\nJournal of urology, 191 (3), 744-749JE Musser, M Assel, JW\r\nMashni, DD Sjoberg, P Russo (2014). “Adult prostate\r\nsarcoma: the Memorial Sloan Kettering experience.” Urology, 84 (3),\r\n624-628M Matignon, R Ding, DM Dadhania, FB Mueller, C\r\nHartono, DD Sjoberg, and others (2014). “Urinary cell\r\nmRNA profiles and differential diagnosis of acute kidney graft\r\ndysfunction.” Journal of the American Society of Nephrology, 25 (7),\r\n1586-1597T Tarin, A Feifer, S Kimm, L Chen, DD\r\nSjoberg, J Coleman, P Russo (2014). “Impact of a common\r\nclinical pathway on length of hospital stay in patients undergoing open\r\nand minimally invasive kidney surgery.” The Journal of urology, 191\r\n(5), 1225-1230T Tarin, A Feifer, S Kimm, L Chen, DD\r\nSjoberg, J Coleman, P Russo (2014). “Impact of a common\r\nclinical pathway on length of hospital stay in patients undergoing open\r\nand minimally invasive kidney surgery.” The Journal of urology, 191\r\n(5), 1225-1230PH Kim, R Sukhu, BH Cordon, JP Sfakianos,\r\nDD Sjoberg, AA Hakimi, and others (2014). “Reflex\r\nfluorescence in situ hybridization assay for suspicious urinary cytology\r\nin bladder cancer patients with negative surveillance cystoscopy.”\r\nBJU international, 114 (3), 354S Carlsson, A Berglund,\r\nDD Sjoberg, A Khatami, J Stranne, S Bergdahl, and\r\nothers (2014). “Effects of surgeon variability on oncologic and\r\nfunctional outcomes in a population-based setting.” BMC urology, 14\r\n(1), 1-8SK Hong, BY Poon, DD Sjoberg, PT\r\nScardino, JA Eastham (2014). “Prostate size and adverse pathologic\r\nfeatures in men undergoing radical prostatectomy.” Urology, 84 (1),\r\n153-157JE Musser, M Assel, GB Guglielmetti, P Pathak, JL\r\nSilberstein, DD Sjoberg, and others (2014). “Impact of\r\nroutine use of surgical drains on incidence of complications with\r\nrobot-assisted radical prostatectomy.” Journal of endourology, 28\r\n(11), 1333-1337KA Moses, LY Chen, DD\r\nSjoberg, M Bernstein, KA Touijer (2014). “Black and White men\r\nyounger than 50 years of age demonstrate similar outcomes after radical\r\nprostatectomy.” BMC urology, 14 (1), 1-6SK Hong, E\r\nVertosick, DD Sjoberg, PT Scardino, JA Eastham (2014).\r\n“Insignificant disease among men with intermediate-risk prostate\r\ncancer.” World journal of urology, 32 (6), 1417-1421M\r\nRieken, RS Djajadiningrat, LA Kluth, RL Favaretto, E Xylinas, DD\r\nSjoberg, and others (2014). “Predictors of cancer-specific\r\nmortality after disease recurrence in patients with squamous cell\r\ncarcinoma of the penis.” European urology, 66 (5),\r\n811-814B Ehdaie, DD Sjoberg, PH Dalecki,\r\nPT Scardino, JA Eastham, D Amar (2014). “Association of anesthesia\r\ntechnique for radical prostatectomy with biochemical recurrence: a\r\nretrospective cohort study.” Canadian Journal of Anesthesia/Journal\r\ncanadien d’anesthésie, 61 (12), 1068-1074S Carlsson, M\r\nAssel, DD Sjoberg (2014). “L’effet du dépistage du\r\ncancer de la prostate, dépend-il du taux du PSA à l’âge de 60 ans?.”\r\nMinerva, 13 (10), 123-124SW Fine, J Chang, JB Poon,\r\nDD Sjoberg, HA Al-Ahmadie, YB Chen, and others (2014).\r\n“Gleason Score 7 with Tertiary Pattern 5: A Contemporary Analysis.”\r\nLABORATORY INVESTIGATION, 94, 227A-228AAJ Vickers, D\r\nUlmert, DD Sjoberg, CJ Bennette, T Björk, A Gerdtsson,\r\nand others (2013). “Strategy for detection of prostate cancer based on\r\nrelation between prostate specific antigen at age 40-55 and long term\r\nrisk of metastasis: case-control study.” Bmj, 346BR\r\nCassileth, KJ Van Zee, KS Yeung, MI Coleton, S Cohen, YH Chan,\r\nDD Sjoberg, and others (2013). “Acupuncture in the\r\ntreatment of upper-limb lymphedema: Results of a pilot study.”\r\nCancer, 119 (13), 2455-2461M Rink, DJ Lee, M Kent, E\r\nXylinas, HM Fritsche, M Babjuk, A Brisuda, DD Sjoberg,\r\nand others (2013). “Predictors of cancer-specific mortality after\r\ndisease recurrence following radical cystectomy.” BJU international,\r\n111 (3b), E30-E36V Margulis, SF Shariat, Y Rapoport, M\r\nRink, DD Sjoberg, NM Tannir, and others (2013).\r\n“Development of accurate models for individualized prediction of\r\nsurvival after cytoreductive nephrectomy for metastatic renal cell\r\ncarcinoma.” European urology, 63 (5), 947-952A\r\nChristensson, C Savage, DD Sjoberg, AM Cronin, M Frank\r\nO’Brien, and others (2013). “Association of cancer with moderately\r\nimpaired renal function at baseline in a large, representative,\r\npopulation-based cohort followed for up to 30 years.” International\r\nJournal of Cancer, 133 (6), 1452-1458G Deng, Y Chan,\r\nDD Sjoberg, A Vickers, KS Yeung, M Kris, D Straus, and\r\nothers (2013). “Acupuncture for the treatment of post-chemotherapy\r\nchronic fatigue: a randomized, blinded, sham-controlled trial.”\r\nSupportive Care in Cancer, 21 (6), 1735-1741SV\r\nCarlsson, LJ Tafe, DC Chade, DD Sjoberg, N Passoni, SF\r\nShariat, and others (2013). “Pathological features of lymph node\r\nmetastasis for predicting biochemical recurrence after radical\r\nprostatectomy for prostate cancer.” The Journal of urology, 189 (4),\r\n1314-1319G Deng, WD Wong, J Guillem, Y Chan, T Affuso, KS\r\nYeung, M Coleton, DD Sjoberg, and others (2013). “A\r\nphase II, randomized, controlled trial of acupuncture for reduction of\r\npostcolectomy ileus.” Annals of surgical oncology, 20 (4),\r\n1164-1169JA Forsberg, DD Sjoberg, QR Chen,\r\nA Vickers, JH Healey (2013). “Treating metastatic disease: which\r\nsurvival model is best suited for the clinic?.” Clinical\r\nOrthopaedics and Related Research®, 471 (3), 843-850AA\r\nHakimi, L Chen, PH Kim, DD Sjoberg, L Glickman, MR\r\nWalker, P Russo (2013). “The impact of metformin use on recurrence and\r\ncancer-specific survival in clinically localized high-risk renal cell\r\ncarcinoma.” Canadian Urological Association Journal, 7 (11-12),\r\nE687AJ Vickers, DD Sjoberg, DP Ankerst, CM\r\nTangen, PJ Goodman, and others (2013). “The Prostate Cancer Prevention\r\nTrial risk calculator and the relationship between prostate-specific\r\nantigen and biopsy outcome.” Cancer, 119 (16),\r\n3007-3011S Carlsson, M Peltola, DD\r\nSjoberg, F Schröder, J Hugosson, K Pettersson, and others\r\n(2013). “Can one blood draw replace transrectal\r\nultrasonography-estimated prostate volume to predict prostate cancer\r\nrisk?.” BJU international, 112 (5), 602JL Silberstein,\r\nPC Sprenkle, D Su, NE Power, TV Tarin, P Ezell, DD\r\nSjoberg, and others (2013). “Neutrophil gelatinase-associated\r\nlipocalin (NGAL) levels in response to unilateral renal ischaemia in a\r\nnovel pilot two-kidney porcine model.” BJU international, 112 (4),\r\n517KA Touijer, CR Mazzola, DD Sjoberg, PT\r\nScardino, JA Eastham (2013). “Reply to Michael Froehner, Rainer Koch,\r\nand Manfred P. Wirth’s letter to the editor re: Karim A. Touijer,\r\nClarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A ….”\r\nEuropean Urology, 65 (2), e25-6W Breitbart, S Poppito,\r\nB Rosenfeld, AJ Vickers, Y Li, J Abbey, M Olden, DD\r\nSjoberg, and others (2012). “Pilot randomized controlled trial\r\nof individual meaning-centered psychotherapy for patients with advanced\r\ncancer.” Journal of clinical oncology, 30 (12), 1304TV\r\nTarin, NE Power, B Ehdaie, JP Sfakianos, JL Silberstein, CJ Savage,\r\nDD Sjoberg, and others (2012). “Lymph node–positive\r\nbladder cancer treated with radical cystectomy and lymphadenectomy:\r\neffect of the level of node positivity.” European urology, 61 (5),\r\n1025-1030M Rink, DD Sjoberg, E Comploj, V\r\nMargulis, E Xylinas, RK Lee, J Hansen, and others (2012). “Risk of\r\ncancer-specific mortality following recurrence after radical\r\nnephroureterectomy.” Annals of surgical oncology, 19 (13),\r\n4337-4344AJ Vickers, DD Sjoberg, E Basch,\r\nF Sculli, M Shouery, V Laudone, and others (2012). “How do you know if\r\nyou are any good? A surgeon performance feedback system for the outcomes\r\nof radical prostatectomy.” European urology, 61 (2),\r\n284A Sankin, JP Sfakianos, J Schiff, DD\r\nSjoberg, JA Coleman (2012). “Assessing renal function after\r\npartial nephrectomy using renal nuclear scintigraphy and estimated\r\nglomerular filtration rate.” Urology, 80 (2), 343-346Y\r\nAhallal, K Braun, DD Sjoberg, T Ghoneim, M Esteban, J\r\nMulhall, and others (2012). “Impact des biopsies répétées sur la\r\nfonction érectile chez les patients sous surveillance active pour cancer\r\nde la prostate.” Progrès en Urologie, 22 (13), 810M\r\nRink, DD Sjoberg, E Comploj, V Margulis, E Xylinas, R\r\nLee, J Hansen, and others (2012). “Time to Disease Recurrence is a\r\nPredictor of Cancer-Specific Mortality After Radical\r\nNephroureterectomy.” UROLOGY, 80 (3), S332-S332HF\r\nHochberg-Garrett, DM Hoelscher, SV Sharma, DD Sjoberg\r\n(2009). “The Skip to Breakfast Project: Development, Implementation, and\r\nEvaluation of an Intervention to Increase Healthful Breakfast\r\nConsumption among Fifth Grade Students and Their ….” Journal of the\r\nAmerican Dietetic Association, 9 (109), A81\r\n\r\n\r\n\r\n\r\n",
      "last_modified": "2022-04-18T21:30:59-04:00"
    },
    {
      "path": "software.html",
      "author": [],
      "contents": "\r\ngtsummary\r\n\r\n\r\n\r\n\r\n\r\n Language R\r\nThe {gtsummary} package provides an elegant and flexible way to\r\ncreate publication-ready analytic and summary tables using the\r\nR programming language. The {gtsummary} package\r\nsummarizes data sets, regression models, and more, using sensible\r\ndefaults with highly customizable capabilities. By leveraging {broom}, {gt}, and {labelled} packages,\r\n{gtsummary} creates beautifully formatted, ready-to-share summary and\r\nresult tables in a single line of R code!\r\n\r\nSummarize\r\ndata frames or tibbles easily in R.\r\nPerfect for presenting descriptive statistics, comparing group\r\ndemographics (e.g creating a Table 1\r\nfor medical journals), and more. Automatically detects continuous,\r\ncategorical, and dichotomous variables in your data set, calculates\r\nappropriate descriptive statistics, and also includes amount of\r\nmissingness in each variable.\r\nSummarize\r\nregression models in R and include reference rows for\r\ncategorical variables. Common regression models, such as logistic\r\nregression and Cox proportional hazards regression, are automatically\r\nidentified and the tables are pre-filled with appropriate column headers\r\n(i.e. Odds Ratio and Hazard Ratio).\r\nCustomize\r\ngtsummary tables using a growing list of formatting/styling\r\nfunctions. Bold\r\nlabels, italicize\r\nlevels, add\r\np-value to summary tables, style\r\nthe statistics however you choose, merge\r\nor stack\r\ntables to present results side by side… there are so many possibilities\r\nto create the table of your dreams!\r\nReport\r\nstatistics inline from summary tables and regression\r\nsummary tables in R markdown. Make your reports\r\ncompletely reproducible!\r\nInstallation Code: install.packages(\"gtsummary\")\r\nMore information at http://www.danieldsjoberg.com/gtsummary/\r\nDecision Curve Analysis\r\n\r\n\r\n\r\n\r\n\r\n Languages R, Stata,\r\nSAS\r\nDecision-analytic techniques allow assessment of clinical outcomes\r\nbut often require collection of additional information may be cumbersome\r\nto apply to models that yield a continuous result. Decision curve\r\nanalysis is a method for evaluating and comparing prediction models that\r\nincorporates clinical consequences, requires only the data set on which\r\nthe models are tested, and can be applied to models that have either\r\ncontinuous or dichotomous results.\r\nDetailed tutorial and installation\r\ninstructions at https://www.danieldsjoberg.com/dca-tutorial/dca-tutorial-r.html\r\nR package website: http://www.danieldsjoberg.com/dcurves/\r\n\r\nVickers AJ, Elkin EB. “Decision curve analysis: a novel method for\r\nevaluating prediction models.” Medical Decision Making. 2006\r\nNov-Dec;26(6):565-74.\r\nVickers AJ, Cronin AM, Elkin EB, Gonen M. “Extensions to decision\r\ncurve analysis, a novel method for evaluating diagnostic tests,\r\nprediction models and molecular markers.” BMC Medical Informatics\r\nand Decision Making. 2008 Nov 26;8(1):53.\r\nstarter\r\nLanguage R\r\nGet started with new projects by dropping a skeleton of a new project\r\ninto a new or existing directory, initialise git repositories, and\r\ncreate reproducible environments with the ‘renv’ package. The package\r\nallows for dynamically named files, folders, file content, as well as\r\nthe functionality to drop individual template files into existing\r\nprojects.\r\nInstallation Code: install.packages(\"starter\")\r\nMore information at http://www.danieldsjoberg.com/starter/\r\nrstudio.prefs\r\n\r\n\r\n\r\n\r\n\r\n Language R\r\nAs of RStudio v1.3, the preferences in the Global Options dialog (and\r\na number of other preferences that aren’t) are now saved in simple,\r\nplain-text JSON files. This package provides an interface for working\r\nwith these RStudio JSON preference files to easily make modifications\r\nwithout using the point-and-click option menus. This is particularly\r\nhelpful when working on teams to ensure a unified experience across\r\nmachines and utilizing settings for best practices.\r\n\r\nInstallation Code: install.packages(\"rstudio.prefs\")\r\nMore information at http://www.danieldsjoberg.com/rstudio.prefs/\r\nbroom.helpers\r\n\r\n\r\n\r\n\r\n\r\n Language R\r\nThe {broom.helpers} package provides suite of functions to work with\r\nregression model broom::tidy() tibbles. The suite includes\r\nfunctions to group regression model terms by variable, insert reference\r\nand header rows for categorical variables, add variable labels, and\r\nmore. {broom.helpers} is used, in particular, by\r\ngtsummary::tbl_regression() for producing nice formatted\r\ntables of model coefficients and by GGally::ggcoef_model()\r\nfor plotting model coefficients.\r\n\r\nInstallation Code: install.packages(\"broom.helpers\")\r\nMore information at https://larmarange.github.io/broom.helpers/\r\nvisR\r\n\r\n\r\n\r\n\r\n\r\n Language R\r\nEnables fit-for-purpose, reusable clinical and medical research\r\nfocused visualizations and tables with sensible defaults and based on\r\nsound graphical principles.\r\n\r\nInstallation Code: install.packages(\"visR\")\r\nMore information at https://openpharma.github.io/visR/\r\nbstfun\r\nLanguage R\r\nA miscellaneous collection of functions to used by members of the\r\nBiostatistics Department at MSKCC. Functions in the {bstfun} package do\r\nnot fall within the well-defined packages with more narrow scope used by\r\nthe department.\r\nInstallation Code:\r\ndevtools::install_github(\"ddsjoberg/bstfun\")\r\nMore information at http://www.danieldsjoberg.com/bstfun/\r\nContributions\r\ngtExtras\r\n\r\n\r\n\r\n\r\n\r\n Language R\r\nThe goal of {gtExtras} is to provide some additional helper functions\r\nto assist in creating beautiful tables with {gt.} The functions are\r\ngenerally wrappers around boilerplate or adding capabilities that are\r\ncurrently not yet built into {gt}. The {gt} package is amazing, make\r\nsure to go read the official documentation.\r\n\r\nInstallation Code:\r\nremotes::install_github(\"jthomasmock/gtExtras\")\r\nMore information at https://jthomasmock.github.io/gtExtras/\r\nbroom\r\n\r\n\r\n\r\n\r\n\r\n Language R\r\nThe {broom} package summarizes key information about models in tidy\r\ntibbles. {broom} provides three verbs to make it convenient to interact\r\nwith model objects: tidy(), glance(), and\r\naugment().\r\n\r\nInstallation Code: install.packages(\"broom\")\r\nMore information at https://broom.tidymodels.org/\r\n\r\n\r\n\r\n",
      "last_modified": "2022-04-18T21:29:03-04:00"
    }
  ],
  "collections": []
}
